Evidences of a New Psychobiotic Formulation on Body Composition and Anxiety.
Carmela ColicaEnnio AvolioPatrizio BolleroRenata Costa de MirandaSimona FerraroPaola Sinibaldi SalimeiAntonino De LorenzoLaura Di RenzoPublished in: Mediators of inflammation (2017)
Three-week intake of selected POS represents a good approach to solve problems related to obesity and behavior disorders. However, new clinical trials need to be performed on a larger population and for a longer period of treatment before definitive conclusions can be made. This trial is registered with NCT01890070.
Keyphrases
- body composition
- clinical trial
- resistance training
- bone mineral density
- phase ii
- metabolic syndrome
- phase iii
- weight gain
- mental health
- insulin resistance
- type diabetes
- study protocol
- weight loss
- drug delivery
- high fat diet induced
- open label
- sleep quality
- randomized controlled trial
- locally advanced
- combination therapy
- body mass index
- squamous cell carcinoma
- high intensity
- postmenopausal women
- physical activity
- replacement therapy